# Cevimeline Hydrochloride

NDC: 70771-1982
Generic name: Cevimeline Hydrochloride
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260415

FDA application: ANDA220267

## Active ingredients

- CEVIMELINE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1982"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1982
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a29e9ab-edb0-4ae8-8f20-f43d122d2b43